USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name: NEPHROS THERAPEUTICS, INC.
City: ANN ARBOR
State: MI
Zip+4: 48105
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Website URL: N/A
Phone: (734) 975-0080

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $275,000.00 4
SBIR Phase II $1,104,700.00 2

Award List:

Tissue Engineering of a Biohybrid Human Kidney Tubule

Award Year / Program / Phase: 1995 / SBIR / Phase I
Agency: HHS
Principal Investigator: Deborah Cieslinski
Award Amount: $100,000.00

Tissue Engineering of a Biohybrid Human Kidney Tubule

Award Year / Program / Phase: 1996 / SBIR / Phase II
Agency: HHS
Principal Investigator: Deborah Cieslinski
Award Amount: $750,000.00
Abstract:
Our research is part of an ongoing program to develop artificial equivalents of the renal glomerulipresent application will to identify the best combination of synthetic materials, biologic compoundsproduce a bioartificial renal tubule. Renal tubular progenitor cells will be grown as a confluent… More

SBIR Phase I: Erythropoientin Cell Therapy in Chronic Renal Failure

Award Year / Program / Phase: 1996 / SBIR / Phase I
Agency: NSF
Principal Investigator: Deborah Cieslinski
Award Amount: $75,000.00

GENE THERAPY DEVICE FOR TREATMENT OF HEMOPHILIA B

Award Year / Program / Phase: 1998 / SBIR / Phase I
Agency: HHS
Principal Investigator: Buffington, Deborah A
Award Amount: $100,000.00

GENE THERAPY DEVICE FOR TREATMENT OF HEMOPHILIA B

Award Year / Program / Phase: 2001 / SBIR / Phase I
Agency: HHS
Principal Investigator: Deborah A. Buffington
Award Amount: $0.00
Abstract:
DESCRIPTION (Unedited Applicant's Abstract): The goal of this proposal is to develop a novel gene therapy delivery device for treatment of the genetic disorder. Hemophilia B. a devastating and costly (over a billion dollar market) disease characterized by spontaneous internal… More

GENE THERAPY DEVICE FOR TREATMENT OF HEMOPHILIA B

Award Year / Program / Phase: 2001 / SBIR / Phase II
Agency: HHS
Principal Investigator: Deborah A. Buffington
Award Amount: $354,700.00
Abstract:
DESCRIPTION (Unedited Applicant's Abstract): The goal of this proposal is to develop a novel gene therapy delivery device for treatment of the genetic disorder. Hemophilia B. a devastating and costly (over a billion dollar market) disease characterized by spontaneous internal… More